Literature DB >> 19565183

A possible paraneoplastic neuromyelitis optica associated with lung cancer.

Giuseppe De Santis1, Luisa Caniatti, Alessandro De Vito, Riccardo De Gennaro, Enrico Granieri, Maria Rosaria Tola.   

Abstract

Neuromyelitis optica is associated with antibodies to aquaporin-4 channels and has been classically defined as the occurrence of bilateral optic neuritis and transverse myelitis with no other neurological involvement. We describe here a 63-year-old woman who presented to our local hospital with an acute, bilateral visual loss followed by progressive paraparesis. Medical evaluations revealed a lung tumor and spinal MRI showed multiple cervical-dorsal hyperintense T(2) lesions with mild mass effect. Testing for NMO-Ig resulted positive. Patient's diagnosis was thus consistent with a possible paraneoplastic neuromyelitis optica associated with non-small cell lung cancer and evidence of NMO-Ig.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19565183     DOI: 10.1007/s10072-009-0112-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  10 in total

1.  The clinical course of neuromyelitis optica (Devic's syndrome).

Authors:  D M Wingerchuk; W F Hogancamp; P C O'Brien; B G Weinshenker
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

Review 2.  Paraneoplastic syndromes involving the nervous system.

Authors:  Robert B Darnell; Jerome B Posner
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

Review 3.  Paraneoplastic syndromes affecting the nervous system.

Authors:  J O Dalmau; J B Posner
Journal:  Semin Oncol       Date:  1997-06       Impact factor: 4.929

4.  Visual disturbances in advanced cancer patients: clinical observations.

Authors:  L Saita; D Polastri; F De Conno
Journal:  J Pain Symptom Manage       Date:  1999-03       Impact factor: 3.612

5.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

Authors:  Vanda A Lennon; Dean M Wingerchuk; Thomas J Kryzer; Sean J Pittock; Claudia F Lucchinetti; Kazuo Fujihara; Ichiro Nakashima; Brian G Weinshenker
Journal:  Lancet       Date:  2004 Dec 11-17       Impact factor: 79.321

6.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

7.  A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

Authors:  Claudia F Lucchinetti; Raul N Mandler; Dorian McGavern; Wolfgang Bruck; Gerald Gleich; Richard M Ransohoff; Corinna Trebst; Brian Weinshenker; Dean Wingerchuk; Joseph E Parisi; Hans Lassmann
Journal:  Brain       Date:  2002-07       Impact factor: 13.501

8.  Aquaporin-4 autoantibodies in a paraneoplastic context.

Authors:  Sean J Pittock; Vanda A Lennon
Journal:  Arch Neurol       Date:  2008-05

Review 9.  The spectrum of neuromyelitis optica.

Authors:  Dean M Wingerchuk; Vanda A Lennon; Claudia F Lucchinetti; Sean J Pittock; Brian G Weinshenker
Journal:  Lancet Neurol       Date:  2007-09       Impact factor: 44.182

10.  A case of paraneoplastic myelopathy associated with the neuromyelitis optica antibody.

Authors:  Sabine Mueller; Dena B Dubal; S Andrew Josephson
Journal:  Nat Clin Pract Neurol       Date:  2008-03-04
  10 in total
  15 in total

1.  Antibodies to aquaporin-4 in non-small cell lung cancer: a study on 50 patients.

Authors:  S Jarius; A Warth; K P Wandinger; P A Schnabel; H Hoffmann; B Wildemann; T Muley
Journal:  Neurol Sci       Date:  2010-05-27       Impact factor: 3.307

2.  Paraneoplastic Neuromyelitis Optica Associated with Lung Adenocarcinoma in a Young Woman.

Authors:  Kyoung Won Baik; Se Hoon Kim; Ha Young Shin
Journal:  J Clin Neurol       Date:  2018-04       Impact factor: 3.077

Review 3.  Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder.

Authors:  Dominique Rosales; Ilya Kister
Journal:  Curr Allergy Asthma Rep       Date:  2016-06       Impact factor: 4.806

4.  Is neuromyelitis optica with advanced age of onset a paraneoplastic disorder?

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Int J Neurosci       Date:  2013-10-31       Impact factor: 2.292

5.  Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies.

Authors:  Maria Sepúlveda; Nuria Sola-Valls; Domingo Escudero; Bojan Rojc; Manuel Barón; Luis Hernández-Echebarría; Begoña Gómez; Josep Dalmau; Albert Saiz; Francesc Graus
Journal:  Mult Scler       Date:  2017-09-18       Impact factor: 6.312

Review 6.  Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.

Authors:  Sean J Pittock; Claudia F Lucchinetti
Journal:  Ann N Y Acad Sci       Date:  2015-06-10       Impact factor: 5.691

7.  Aquaporin-4-Positive Triple-Negative Breast Cancer Presenting with Paraneoplastic Neuromyelitis Optica Spectrum Disorder.

Authors:  Pilar Carrillo; Teresa Gorría; Daniel Santana; Maria Sepulveda; Iban Aldecoa; Blanca Gonzalez-Farré; Esther Sanfeliu; Eduard Mension; Isaac Cebrecos; Olga Martínez-Saez; Imma Alonso; Albert Saiz
Journal:  Biomed Hub       Date:  2022-01-31

8.  Long extensive transverse myelitis associated with aquaporin-4 antibody and breast cancer: favorable response to cancer treatment.

Authors:  Haydar Armağan; Erdem Tüzün; Sema Içöz; Omer Birişik; Canan Ulusoy; Gökhan Demir; Ayşe Altıntaş; Gülşen Akman-Demir
Journal:  J Spinal Cord Med       Date:  2012-07       Impact factor: 1.985

9.  Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4.

Authors:  Michelle Figueroa; Yong Guo; Alexandros Tselis; Sean J Pittock; Vanda A Lennon; Claudia F Lucchinetti; Robert P Lisak
Journal:  JAMA Neurol       Date:  2014-04       Impact factor: 18.302

10.  Paraneoplastic neuromyelitis optica spectrum disorder associated with malignant melanoma: A case report.

Authors:  Toshiki Morimoto; Shotaro Hayashida; Kei Yamasaki; Yosuke Sasahara; Tsutomu Takaki; Kazuhiro Yatera
Journal:  Thorac Cancer       Date:  2021-05-05       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.